Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCsChangsung Kim, Huei-Sheng Vincent Chen, Johnson Wong et al.|Nature|2013Cited by 523
Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D. Gillmore, Jonathan C. Fox, José Nativi-Nicolau et al.|New England Journal of Medicine|2024Cited by 453
Efficacy and safety of tafamidis doses in the <scp>Tafamidis in Transthyretin Cardiomyopathy Clinical Trial</scp> ( <scp>ATTR‐ACT</scp> ) and long‐term extension studyThibaud Damy, Ronald Witteles, Pablo García‐Pavía et al.|European Journal of Heart Failure|2020Cited by 207
Genetic and Phenotypic Landscape of Peripartum CardiomyopathyRahul Goli, Jian Li, Jeff Brandimarto et al.|Circulation|2021Cited by 181
Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathyStephen P. Chelko, Daniel P. Judge|JCI Insight|2016Cited by 177